...
首页> 外文期刊>Oncology Research >CSTB Downregulation Promotes Cell Proliferation and Migration and Suppresses Apoptosis in Gastric Cancer SGC-7901 Cell Line
【24h】

CSTB Downregulation Promotes Cell Proliferation and Migration and Suppresses Apoptosis in Gastric Cancer SGC-7901 Cell Line

机译:CSTB下调促进胃癌SGC-7901细胞株的细胞增殖和迁移并抑制细胞凋亡。

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to investigate the pivotal role of cystatin B (CSTB) in the development of gastric cancer and to explore its possible regulatory mechanism. Human gastric cancer SGC-7901 cells as a model in vitro were transfected with plasmid PCDNA3.1-CSTB and siRNA-CSTB using Lipofectamine 2000. Quantitative real-time PCR (qRT-PCR) and Western blotting were performed to determine the relative expression of CSTB and PI3K/Akt/mTOR pathway-related protein. Moreover, MTT assay, Transwell assay, and flow cytometry were used to assess cell proliferation, migration, and apoptosis, respectively. The results showed that CSTB was significantly downregulated in SGC-7901 cells compared with gastric epithelial cells. CSTB was successfully overexpressed and suppressed after cells were transfected with pc-CSTB and si-CSTB, respectively. Moreover, cell viability and migration were significantly decreased after being transfected with pc-CSTB when compared with the control group, while being obviously increased after transfection with si-CSTB. However, cell apoptosis was significantly induced after being transfected with pc-CSTB, while being obviously suppressed after transfection with si-CSTB. Besides, the expression levels of p-PI3K, p-Akt, and p-mTOR proteins were all significantly decreased in the pc-CSTB transfection group when compared with the control group, while being increased in the si-CSTB transfection group. Our findings suggest that CSTB downregulation may promote the development of gastric cancer by affecting cell proliferation and migration, and the PI3K/Akt/mTOR signaling pathway was activated in this process. CSTB may serve as a potential therapeutic target for gastric cancer.
机译:这项研究旨在调查胱抑素B(CSTB)在胃癌发展中的关键作用,并探讨其可能的调控机制。使用Lipofectamine 2000用质粒PCDNA3.1-CSTB和siRNA-CSTB转染体外作为模型的人胃癌SGC-7901细胞。进行定量实时PCR(qRT-PCR)和Western blotting以确定其相对表达CSTB和PI3K / Akt / mTOR通路相关蛋白。而且,MTT测定,Transwell测定和流式细胞术分别用于评估细胞增殖,迁移和凋亡。结果表明,与胃上皮细胞相比,SGC-7901细胞中CSTB的表达显着下调。分别用pc-CSTB和si-CSTB转染细胞后,CSTB成功地被过表达和抑制。而且,与对照组相比,pc-CSTB转染后细胞活力和迁移明显降低,而si-CSTB转染后细胞活力和迁移明显增加。然而,转染pc-CSTB后细胞凋亡明显被诱导,而转染si-CSTB后细胞凋亡被明显抑制。此外,与对照组相比,在pc-CSTB转染组中p-PI3K,p-Akt和p-mTOR蛋白的表达水平均显着降低,而在si-CSTB转染组中则升高。我们的发现表明CSTB的下调可能通过影响细胞的增殖和迁移来促进胃癌的发展,并且在此过程中激活了PI3K / Akt / mTOR信号通路。 CSTB可能成为胃癌的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号